LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23 | -17.9% | 19,565 | 0.0% | 0.00% | – |
Q2 2023 | $28 | -99.9% | 19,565 | +29.0% | 0.00% | – |
Q1 2022 | $23,000 | -71.2% | 15,165 | -53.5% | 0.00% | – |
Q4 2021 | $80,000 | +90.5% | 32,612 | +97.1% | 0.00% | – |
Q3 2021 | $42,000 | -14.3% | 16,543 | -3.1% | 0.00% | – |
Q2 2021 | $49,000 | +276.9% | 17,067 | +11.9% | 0.00% | – |
Q1 2020 | $13,000 | -13.3% | 15,254 | -7.3% | 0.00% | – |
Q4 2019 | $15,000 | +7.1% | 16,451 | +13.1% | 0.00% | – |
Q3 2019 | $14,000 | – | 14,548 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 4,735,990 | $8,335,000 | 3.63% |
BROADWOOD CAPITAL INC | 34,005,379 | $59,849,000 | 3.55% |
Prescott General Partners LLC | 1,851,851 | $3,259,000 | 0.14% |
Strategic Wealth Investment Group, LLC | 66,917 | $118,000 | 0.07% |
Laidlaw Wealth Management LLC | 170,658 | $300,000 | 0.06% |
Humankind Investments LLC | 26,737 | $47,000 | 0.05% |
DAFNA Capital Management LLC | 80,000 | $141,000 | 0.04% |
Beirne Wealth Consulting Services, LLC | 45,000 | $79,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 680,839 | $1,198,000 | 0.02% |
Allegheny Financial Group LTD | 20,000 | $35,000 | 0.02% |